BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33684416)

  • 1. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
    Koyanagi M; Imai S; Iwamitsu Y; Matsumoto M; Saigo M; Moriya A; Ogihara T; Nakazato Y; Yonezawa A; Nakagawa S; Nakagawa T; Matsubara K
    Neuropharmacology; 2021 May; 188():108514. PubMed ID: 33684416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
    Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
    Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms.
    Imai S; Koyanagi M; Azimi Z; Nakazato Y; Matsumoto M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Wakatsuki S; Araki T; Kaneko S; Nakagawa T; Matsubara K
    Sci Rep; 2017 Jul; 7(1):5947. PubMed ID: 28729624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
    Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
    Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of biomarkers and new therapies for taxane-induced peripheral neuropathy].
    Koyanagi M; Imai S; Nakagawa T; Matsubara K
    Nihon Yakurigaku Zasshi; 2019; 154(5):241-244. PubMed ID: 31735751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
    Tonello R; Lee SH; Berta T
    J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
    Chen YF; Chen LH; Yeh YM; Wu PY; Chen YF; Chang LY; Chang JY; Shen MR
    Sci Rep; 2017 Mar; 7():45366. PubMed ID: 28349969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
    Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
    J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
    Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
    J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cilostazol on preventing paclitaxel-induced neuropathy in patients with breast cancer: A randomized controlled trial.
    Haroun EA; Mansour NO; Eltantawy A; Shams MEE
    Pharmacotherapy; 2023 Sep; 43(9):872-882. PubMed ID: 37199288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
    Sekiguchi F; Domoto R; Nakashima K; Yamasoba D; Yamanishi H; Tsubota M; Wake H; Nishibori M; Kawabata A
    Neuropharmacology; 2018 Oct; 141():201-213. PubMed ID: 30179591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.
    Peters CM; Jimenez-Andrade JM; Jonas BM; Sevcik MA; Koewler NJ; Ghilardi JR; Wong GY; Mantyh PW
    Exp Neurol; 2007 Jan; 203(1):42-54. PubMed ID: 17005179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
    Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
    Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
    Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
    J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
    Wozniak KM; Vornov JJ; Wu Y; Liu Y; Carozzi VA; Rodriguez-Menendez V; Ballarini E; Alberti P; Pozzi E; Semperboni S; Cook BM; Littlefield BA; Nomoto K; Condon K; Eckley S; DesJardins C; Wilson L; Jordan MA; Feinstein SC; Cavaletti G; Polydefkis M; Slusher BS
    Cancer Res; 2018 Feb; 78(3):817-829. PubMed ID: 29191802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA
    Szepanowski F; Szepanowski LP; Mausberg AK; Kleinschnitz C; Kieseier BC; Stettner M
    Neurosci Lett; 2018 Jan; 662():136-141. PubMed ID: 29051083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice.
    Sankaranarayanan I; Tavares-Ferreira D; Mwirigi JM; Mejia GL; Burton MD; Price TJ
    J Neuroinflammation; 2023 Feb; 20(1):32. PubMed ID: 36774519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
    Resham K; Sharma SS
    Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
    Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
    J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.